[Complications of intracavernous pharmacologic infusion in impotence. Long-term results] - PubMed (original) (raw)
[Article in Italian]
Affiliations
- PMID: 8278876
[Complications of intracavernous pharmacologic infusion in impotence. Long-term results]
[Article in Italian]
S Pastorini et al. Minerva Urol Nefrol. 1993 Sep.
Abstract
The large scale employment in recent years of vasoactive drugs in the treatment of impotence forms the basis for a significant statistical study on incidence of complications and collateral effects. We studied 658 patients submitted to ICF (intracavernous pharmacoinfusion) diagnostic and therapeutic in the last 6 years (1986-1992). The patients have been shared groups according to the period and the treatment: in 226 cases we have utilized papaverine, in 224 cases phentolamine-papaverine association and in 208 cases prostaglandin E1. In the last group the complications have been lower: echymosis and haematoma 0.5%, priapism 1.5%, intracavernous fibrosis 1%, fibrotic knots 0.5%. In conclusion we confirm the validity of treatment with PGE1 intracavernous infusion.
Similar articles
- Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
Meinhardt W, Lycklama à Nijeholt AA, Kropman RF, Vermeij P, Zwartendijk J. Meinhardt W, et al. Eur Urol. 1994;26(4):319-21. doi: 10.1159/000475407. Eur Urol. 1994. PMID: 7713130 Clinical Trial. - Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
Valdevenito R, Melman A. Valdevenito R, et al. Int J Impot Res. 1994 Jun;6(2):81-91. Int J Impot Res. 1994. PMID: 7951702 Clinical Trial. - Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
Lee LM, Stevenson RW, Szasz G. Lee LM, et al. J Urol. 1989 Mar;141(3):549-50. doi: 10.1016/s0022-5347(17)40889-5. J Urol. 1989. PMID: 2918589 Clinical Trial. - Erectile dysfunction: intracavernous treatment.
Ledda A. Ledda A. Curr Med Res Opin. 2000;16 Suppl 1:s59-62. doi: 10.1185/0300799009117041. Curr Med Res Opin. 2000. PMID: 11329824 Review.
Cited by
- Erectile dysfunction.
Khera M, Goldstein I. Khera M, et al. BMJ Clin Evid. 2011 Jun 29;2011:1803. BMJ Clin Evid. 2011. PMID: 21711956 Free PMC article. Review. - Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction.
Lea AP, Bryson HM, Balfour JA. Lea AP, et al. Drugs Aging. 1996 Jan;8(1):56-74. doi: 10.2165/00002512-199608010-00009. Drugs Aging. 1996. PMID: 8785470 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical